Innophos Holdings Inc Presents at Oppenheimer's Eighth Annual Industrial Growth Summit, May-15-2013 . Venue: InterContinental Barclay Hotel, 111 East 48(th) Street, New York, New York, United States.

Innophos Holdings Inc. announced that its Board of Directors had declared a quarterly dividend of $0.35 per share of common stock. The dividend will be payable on May 31, 2013 to stockholders of record as of the close of business on May 17, 2013.

Innophos Holdings Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported net sales of $214,441,000 against $228,252,000 for the same period of previous year. Operating income was $17,925,000 against $38,139,000 a year ago. Income before income taxes was $17,271,000 against $36,803,000 a year ago. Net income was $12,403,000 or $0.55 per diluted share against $27,588,000 or $1.22 per diluted share a year ago. Net cash provided from operating activities was $35,556,000 against $29,860,000 a year ago. Capital expenditures were $7,437,000 against $5,200,000 a year ago, below primarily due to some expenditures accelerated into the fourth quarter 2012. Net debt decreased by $21 million in the 2013 first quarter to $128 million as a result of reduced working capital in Mexico. The company provided earnings guidance for the full year 2012. Management continues to expect only modest market growth in 2013. Momentum behind growth strategy continues to improve, as evidenced by record export sales from the U.S. for the first quarter 2013, particularly to Asia Pacific and Europe. Recently granted food manufacturing license in Taicang, China allows to begin operations there and build on a strong start to the year in that zone. The company continue to expect growth in Specialty Phosphates for the second half of 2013 excluding the benefit of recent acquisitions, to be within 4-6% long-term target range. Strong performance by recent acquisitions is expected to continue, and this, together with the full year benefit of the two acquisitions made in 2012, is expected to contribute an additional 5% revenue growth for the full year 2013 in comparison to 2012. Going forward the company anticipates an effective tax rate in the 32% to 34% range. The company continues to expect 2013 capital expenditures to remain in the $40 million to $45 million range. For the full year, the company expects depreciation and amortization to be $7 million less than in 2012, with approximately $4.5 million benefiting Specialty Phosphates.